Chicago Partners Investment Group LLC Vaxcyte, Inc. Transaction History
Chicago Partners Investment Group LLC
- $2.81 Billion
- Q3 2024
A detailed history of Chicago Partners Investment Group LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 4,973 shares of PCVX stock, worth $414,250. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,973
Previous 5,066
1.84%
Holding current value
$414,250
Previous $382,000
48.43%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding PCVX
# of Institutions
353Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$953 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$910 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$828 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$724 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$408 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.94B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...